These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7669003)

  • 1. [Regression of human coronary atherosclerosis. Mechanisms and clinical implications].
    da Luz PL; Solimene MC; Pileggi F
    Arq Bras Cardiol; 1995 Jan; 64(1):1-6. PubMed ID: 7669003
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations.
    Lansky AJ; Desai K; Leon MB
    Am J Cardiol; 2002 Feb; 89(4A):4B-9B. PubMed ID: 11879660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regression and therapy of atherosclerosis: regression of treated atherosclerosis viewed by coronary angiography].
    Nishimura S; Nakanishi S; Nishiyama S; Seki A; Yamaguchi H
    Nihon Rinsho; 1988 Mar; 46(3):679-85. PubMed ID: 3404695
    [No Abstract]   [Full Text] [Related]  

  • 4. [The relationship between clinical events and the angiographic lesions in coronary atherosclerosis. Hypolipemic treatment and plaque stabilization].
    Castro Beiras A; Vázquez Rodríguez JM; Muñiz J; Calviño R; Vázquez González N; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 5():23-30. PubMed ID: 7494936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study].
    Castaigne A; Albo C; Pham I; Saal JP; Verschuren P
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of a UHF electrical field used bitemporally on the clinical status of patients with ischemic heart disease and atherosclerotic lesions of the coronary arteries (II--III degrees of stenosis)].
    Artikulova IN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (5):16-9. PubMed ID: 8266660
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of coronary atherosclerosis.
    Loscalzo J
    N Engl J Med; 1990 Nov; 323(19):1337-9. PubMed ID: 2215620
    [No Abstract]   [Full Text] [Related]  

  • 8. Is regression of atherosclerosis possible?
    Hugenholtz PG; de Feyter PJ
    Cardiologia; 1992 Jun; 37(6):393-401. PubMed ID: 1394347
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials.
    de Feyter PJ; Serruys PW; Davies MJ; Richardson P; Lubsen J; Oliver MF
    Circulation; 1991 Jul; 84(1):412-23. PubMed ID: 2060112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiographic regression of coronary atheromatosis].
    Szamosi A
    Lakartidningen; 1991 Apr; 88(15):1365-7. PubMed ID: 2020234
    [No Abstract]   [Full Text] [Related]  

  • 11. Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
    Marchioli R; Prieto JC; Tognoni G
    Clin Trials Metaanal; 1994 Oct; 29(2-3):139-76. PubMed ID: 10150224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can life-style changes reverse coronary atherosclerosis?
    Ornish D
    Hosp Pract (Off Ed); 1991 May; 26(5):123-6, 129-32. PubMed ID: 2030112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (XII). Pharmacologic interventions in the progression of coronary atherosclerosis].
    Rayo Llerena I; Marín Huerta E
    Rev Esp Cardiol; 1995 May; 48(5):341-58. PubMed ID: 7792429
    [No Abstract]   [Full Text] [Related]  

  • 14. Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.
    Brown BG; Zhao XQ; Sacco DE; Albers JJ
    Annu Rev Med; 1993; 44():365-76. PubMed ID: 8476257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiographic progression and regression of coronary atherosclerosis].
    Nakanishi S; Seki A; Iwase T; Kato K
    Nihon Ronen Igakkai Zasshi; 1990 Jul; 27(4):416-8. PubMed ID: 2232310
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and angiographic profile and selection of patients for coronary angioplasty of restenosis].
    Gottschall CA
    Arq Bras Cardiol; 1995 Sep; 65(3):259-61. PubMed ID: 8579515
    [No Abstract]   [Full Text] [Related]  

  • 17. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis. Implications for clinical trials.
    Waters D; Lespérance J; Craven TE; Hudon G; Gillam LD
    Circulation; 1993 Mar; 87(3 Suppl):II38-47. PubMed ID: 8443922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram.
    Fuster V; Badimon JJ
    Eur Heart J; 1995 Jul; 16 Suppl E():6-12. PubMed ID: 8542888
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression and stabilization of coronary artery lesions. Angiographic trials move beyond the NCEP treatment guidelines.
    DeBoer LW; Vailas LI
    Nebr Med J; 1992 Jun; 77(6):124-9. PubMed ID: 1620266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.